Brief: Dice Therapeutics Reports First Quarter 2023 Financial Results
May 11 (Reuters) - Dice Therapeutics Inc DICE.O :
* DICE THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
* DICE THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES TOTALED $554.5 MILLION AT MARCH 31, 2023
* DICE THERAPEUTICS INC - EXPECTS ITS CURRENT CASH POSITION
TO
FUND OPERATIONS THROUGH EXPECTED KEY CLINICAL MILESTONES AND
INTO 2026
Source text for Eikon: ID:nGNX47QrSb
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources